Search results
What Medicare beneficiaries need to know about generic medications
Fortune via Yahoo Finance· 1 day agoBut if you think all generics are the same regarding side effects, manufacturing quality, price, and...
Best Medicare Supplement Plan G Companies in 2024 - NerdWallet
Nerdwallet· 2 days agoCheck out the best options for Medicare Supplement Plan G based on pricing, customer satisfaction...
Helius Medical Technologies Inc (HSDT) Q1 2024 Earnings Call Tra
Guru Focus· 2 days agoTotal Revenue: $135,000 for Q1 2024, up $24,000 from $111,000 in Q1 2023.Cost of Revenue: $123,000 for Q1 2024, relatively flat compared to $122,000 in Q1 2023
Senseonics Holdings Inc (SENS) (Q1 2024) Earnings Call Transcrip
Guru Focus· 3 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Senseonics Holdings Inc (SENS, Financial) reported a 22% growth in total revenue, reaching ...
Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise
MedPage Today· 6 days agoNews, features, and commentary about cancer-related issues
Kids and Anti-Obesity Meds: Real-World Challenges
Medscape· 6 days agoWeighing in on the issues, experts at Obesity Medicine (OMA) 2024 offered some key strategies and practice hacks for overcoming those hurdles.
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge
Medical Xpress· 7 days agoEvery day, he takes eight of the 120-milligram pills, sold under Amgen's brand name Lumakras....
Trump Leads Biden in New Battleground Polls. The Economic Stakes Are High.
Barrons.com· 3 days agoIt lowered some prescription drug prices, which is expected to save Medicare hundreds of billions of...
2 Revolutionary Growth Stocks to Buy in the 2024 Bull Market
Motley Fool via Yahoo Finance· 3 days agoThis was driven by a 54% increase on the international side and a 12% increase in the Americas. The...
Q1 2024 Arcutis Biotherapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 12 hours agoBut with continued growth, we expect this growth trend to be well along to the large Seb Derm market with over 4.4 million prescription treated patients in the US Derm office and no other competitive ...
